eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
5.60
-0.42 (-6.98%)
Jul 20, 2026, 4:00 PM EDT - Market closed
eXoZymes Employees
eXoZymes had 32 employees as of December 31, 2025. The number of employees increased by 1 or 3.23% compared to the previous year.
Employees
32
Change (1Y)
1
Growth (1Y)
3.23%
Revenue / Employee
n/a
Profits / Employee
-$302,268
Market Cap
46.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32 | 1 | 3.23% |
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| Mereo BioPharma Group | 39 |
| INmune Bio | 21 |
| Filana Therapeutics | 20 |
| Instil Bio | 17 |
| MiNK Therapeutics | 15 |
EXOZ News
- 5 days ago - eXoZymes Inc trading resumes - TheFly
- 5 days ago - eXoZymes Inc trading halted, volatility trading pause - TheFly
- 26 days ago - eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - Accesswire
- 4 weeks ago - eXoZymes Inc. Announces Closing of $6 Million Public Offering - Accesswire
- 6 weeks ago - eXoZymes prices 592,270 shares at $18.00 in public offering - TheFly
- 6 weeks ago - eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - Accesswire
- 2 months ago - eXoZymes Quarterly report: Q1 2026 - Filings
- 2 months ago - eXoZymes announces graduation from Shell GameChanger Accelerator - TheFly